nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—SLC22A8—Mercaptopurine—Crohn's disease	0.344	0.509	CbGbCtD
Ranitidine—CYP3A5—Sulfasalazine—Crohn's disease	0.134	0.198	CbGbCtD
Ranitidine—CYP2C19—Prednisone—Crohn's disease	0.0862	0.128	CbGbCtD
Ranitidine—ABCB1—Prednisone—Crohn's disease	0.0695	0.103	CbGbCtD
Ranitidine—CYP3A4—Prednisone—Crohn's disease	0.0417	0.0617	CbGbCtD
Ranitidine—Nephrotoxicity—Mesalazine—Crohn's disease	0.00884	0.0313	CcSEcCtD
Ranitidine—Breast feeding—Mesalazine—Crohn's disease	0.00804	0.0285	CcSEcCtD
Ranitidine—Meningitis—Azathioprine—Crohn's disease	0.00796	0.0282	CcSEcCtD
Ranitidine—Bone marrow depression—Mercaptopurine—Crohn's disease	0.00767	0.0272	CcSEcCtD
Ranitidine—Pancreatitis acute—Mesalazine—Crohn's disease	0.00609	0.0216	CcSEcCtD
Ranitidine—Nephropathy—Mesalazine—Crohn's disease	0.0059	0.0209	CcSEcCtD
Ranitidine—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.00518	0.0184	CcSEcCtD
Ranitidine—Foetor hepaticus—Mesalazine—Crohn's disease	0.00495	0.0176	CcSEcCtD
Ranitidine—Nephropathy toxic—Mesalazine—Crohn's disease	0.00489	0.0173	CcSEcCtD
Ranitidine—Bone marrow depression—Azathioprine—Crohn's disease	0.00457	0.0162	CcSEcCtD
Ranitidine—Bone marrow depression—Mesalazine—Crohn's disease	0.00416	0.0148	CcSEcCtD
Ranitidine—Liver disorder—Mesalazine—Crohn's disease	0.00412	0.0146	CcSEcCtD
Ranitidine—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00389	0.0901	CbGpPWpGaD
Ranitidine—SLC22A8—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00389	0.0901	CbGpPWpGaD
Ranitidine—Meningitis—Prednisone—Crohn's disease	0.00383	0.0136	CcSEcCtD
Ranitidine—SLC22A1—Organic cation transport—SLC22A4—Crohn's disease	0.00372	0.0862	CbGpPWpGaD
Ranitidine—SLC22A1—Organic cation transport—SLC22A5—Crohn's disease	0.00372	0.0862	CbGpPWpGaD
Ranitidine—Tubulointerstitial nephritis—Mesalazine—Crohn's disease	0.00367	0.013	CcSEcCtD
Ranitidine—Jaundice cholestatic—Azathioprine—Crohn's disease	0.00351	0.0124	CcSEcCtD
Ranitidine—Breast disorder—Mercaptopurine—Crohn's disease	0.0034	0.012	CcSEcCtD
Ranitidine—Blood disorder—Mesalazine—Crohn's disease	0.00336	0.0119	CcSEcCtD
Ranitidine—Delirium—Mesalazine—Crohn's disease	0.00327	0.0116	CcSEcCtD
Ranitidine—Pancreatitis acute—Prednisone—Crohn's disease	0.00322	0.0114	CcSEcCtD
Ranitidine—Jaundice cholestatic—Mesalazine—Crohn's disease	0.0032	0.0113	CcSEcCtD
Ranitidine—Pancreatitis—Mercaptopurine—Crohn's disease	0.00318	0.0113	CcSEcCtD
Ranitidine—Vasculitis—Azathioprine—Crohn's disease	0.00316	0.0112	CcSEcCtD
Ranitidine—Hepatocellular injury—Azathioprine—Crohn's disease	0.00308	0.0109	CcSEcCtD
Ranitidine—Pancytopenia—Mercaptopurine—Crohn's disease	0.00308	0.0109	CcSEcCtD
Ranitidine—Aplastic anaemia—Azathioprine—Crohn's disease	0.0029	0.0103	CcSEcCtD
Ranitidine—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00284	0.0101	CcSEcCtD
Ranitidine—Hepatocellular injury—Mesalazine—Crohn's disease	0.00281	0.00996	CcSEcCtD
Ranitidine—Aplastic anaemia—Mesalazine—Crohn's disease	0.00264	0.00935	CcSEcCtD
Ranitidine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A5—Crohn's disease	0.00252	0.0584	CbGpPWpGaD
Ranitidine—SLC22A1—Organic cation/anion/zwitterion transport—SLC22A4—Crohn's disease	0.00252	0.0584	CbGpPWpGaD
Ranitidine—Hepatic failure—Azathioprine—Crohn's disease	0.00249	0.00883	CcSEcCtD
Ranitidine—Photosensitivity—Mesalazine—Crohn's disease	0.00232	0.00824	CcSEcCtD
Ranitidine—Alopecia—Mercaptopurine—Crohn's disease	0.0023	0.00815	CcSEcCtD
Ranitidine—Hepatic failure—Mesalazine—Crohn's disease	0.00227	0.00805	CcSEcCtD
Ranitidine—Delusion—Prednisone—Crohn's disease	0.0021	0.00745	CcSEcCtD
Ranitidine—Anaemia—Mercaptopurine—Crohn's disease	0.00209	0.00742	CcSEcCtD
Ranitidine—Mania—Prednisone—Crohn's disease	0.00204	0.00725	CcSEcCtD
Ranitidine—Leukopenia—Mercaptopurine—Crohn's disease	0.00203	0.00718	CcSEcCtD
Ranitidine—Arthralgia—Mercaptopurine—Crohn's disease	0.00193	0.00683	CcSEcCtD
Ranitidine—Blood creatinine increased—Mesalazine—Crohn's disease	0.00191	0.00677	CcSEcCtD
Ranitidine—Pancreatitis—Azathioprine—Crohn's disease	0.0019	0.00673	CcSEcCtD
Ranitidine—Abdominal pain upper—Mesalazine—Crohn's disease	0.00186	0.0066	CcSEcCtD
Ranitidine—Abdominal discomfort—Azathioprine—Crohn's disease	0.00186	0.00658	CcSEcCtD
Ranitidine—Breast disorder—Mesalazine—Crohn's disease	0.00184	0.00653	CcSEcCtD
Ranitidine—Pancytopenia—Azathioprine—Crohn's disease	0.00184	0.00652	CcSEcCtD
Ranitidine—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00181	0.00641	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Mesalazine—Crohn's disease	0.0018	0.00638	CcSEcCtD
Ranitidine—Dysphagia—Mesalazine—Crohn's disease	0.00176	0.00625	CcSEcCtD
Ranitidine—Eosinophilia—Mesalazine—Crohn's disease	0.00175	0.00619	CcSEcCtD
Ranitidine—Pneumonia—Azathioprine—Crohn's disease	0.00174	0.00615	CcSEcCtD
Ranitidine—Bronchospasm—Mesalazine—Crohn's disease	0.00173	0.00615	CcSEcCtD
Ranitidine—Delirium—Prednisone—Crohn's disease	0.00173	0.00613	CcSEcCtD
Ranitidine—Pancreatitis—Mesalazine—Crohn's disease	0.00173	0.00613	CcSEcCtD
Ranitidine—Angina pectoris—Mesalazine—Crohn's disease	0.00172	0.00609	CcSEcCtD
Ranitidine—Abdominal discomfort—Mesalazine—Crohn's disease	0.00169	0.00599	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00168	0.00597	CcSEcCtD
Ranitidine—Pancytopenia—Mesalazine—Crohn's disease	0.00167	0.00594	CcSEcCtD
Ranitidine—Neutropenia—Mesalazine—Crohn's disease	0.00165	0.00584	CcSEcCtD
Ranitidine—Agranulocytosis—Azathioprine—Crohn's disease	0.00161	0.00571	CcSEcCtD
Ranitidine—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00161	0.0057	CcSEcCtD
Ranitidine—Weight decreased—Mesalazine—Crohn's disease	0.00159	0.00565	CcSEcCtD
Ranitidine—Pneumonia—Mesalazine—Crohn's disease	0.00158	0.00561	CcSEcCtD
Ranitidine—Jaundice—Mesalazine—Crohn's disease	0.00153	0.00543	CcSEcCtD
Ranitidine—Vasculitis—Prednisone—Crohn's disease	0.00152	0.0054	CcSEcCtD
Ranitidine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CPEB4—Crohn's disease	0.00151	0.035	CbGpPWpGaD
Ranitidine—Sweating—Mesalazine—Crohn's disease	0.00151	0.00534	CcSEcCtD
Ranitidine—Agranulocytosis—Mesalazine—Crohn's disease	0.00147	0.0052	CcSEcCtD
Ranitidine—Erythema multiforme—Azathioprine—Crohn's disease	0.00146	0.00519	CcSEcCtD
Ranitidine—Body temperature increased—Mercaptopurine—Crohn's disease	0.00146	0.00518	CcSEcCtD
Ranitidine—Hepatitis—Mesalazine—Crohn's disease	0.00141	0.005	CcSEcCtD
Ranitidine—Arrhythmia—Azathioprine—Crohn's disease	0.00138	0.00491	CcSEcCtD
Ranitidine—Alopecia—Azathioprine—Crohn's disease	0.00137	0.00485	CcSEcCtD
Ranitidine—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00136	0.00482	CcSEcCtD
Ranitidine—Erythema multiforme—Mesalazine—Crohn's disease	0.00133	0.00473	CcSEcCtD
Ranitidine—Diarrhoea—Mercaptopurine—Crohn's disease	0.00126	0.00448	CcSEcCtD
Ranitidine—Ill-defined disorder—Azathioprine—Crohn's disease	0.00125	0.00444	CcSEcCtD
Ranitidine—Alopecia—Mesalazine—Crohn's disease	0.00125	0.00442	CcSEcCtD
Ranitidine—Anaemia—Azathioprine—Crohn's disease	0.00125	0.00442	CcSEcCtD
Ranitidine—Erythema—Mesalazine—Crohn's disease	0.00123	0.00435	CcSEcCtD
Ranitidine—Malaise—Azathioprine—Crohn's disease	0.00122	0.00431	CcSEcCtD
Ranitidine—Leukopenia—Azathioprine—Crohn's disease	0.00121	0.00428	CcSEcCtD
Ranitidine—Vomiting—Mercaptopurine—Crohn's disease	0.00117	0.00416	CcSEcCtD
Ranitidine—Rash—Mercaptopurine—Crohn's disease	0.00116	0.00413	CcSEcCtD
Ranitidine—Dermatitis—Mercaptopurine—Crohn's disease	0.00116	0.00413	CcSEcCtD
Ranitidine—Vision blurred—Mesalazine—Crohn's disease	0.00116	0.0041	CcSEcCtD
Ranitidine—Arthralgia—Azathioprine—Crohn's disease	0.00115	0.00407	CcSEcCtD
Ranitidine—Myalgia—Azathioprine—Crohn's disease	0.00115	0.00407	CcSEcCtD
Ranitidine—Ill-defined disorder—Mesalazine—Crohn's disease	0.00114	0.00404	CcSEcCtD
Ranitidine—Anaemia—Mesalazine—Crohn's disease	0.00114	0.00403	CcSEcCtD
Ranitidine—Discomfort—Azathioprine—Crohn's disease	0.00113	0.00402	CcSEcCtD
Ranitidine—Angioedema—Mesalazine—Crohn's disease	0.00112	0.00398	CcSEcCtD
Ranitidine—Malaise—Mesalazine—Crohn's disease	0.00111	0.00393	CcSEcCtD
Ranitidine—Vertigo—Mesalazine—Crohn's disease	0.0011	0.00391	CcSEcCtD
Ranitidine—Leukopenia—Mesalazine—Crohn's disease	0.0011	0.0039	CcSEcCtD
Ranitidine—Nausea—Mercaptopurine—Crohn's disease	0.0011	0.00389	CcSEcCtD
Ranitidine—Thrombocytopenia—Azathioprine—Crohn's disease	0.00108	0.00382	CcSEcCtD
Ranitidine—Myalgia—Mesalazine—Crohn's disease	0.00105	0.00371	CcSEcCtD
Ranitidine—Chest pain—Mesalazine—Crohn's disease	0.00105	0.00371	CcSEcCtD
Ranitidine—Arthralgia—Mesalazine—Crohn's disease	0.00105	0.00371	CcSEcCtD
Ranitidine—Discomfort—Mesalazine—Crohn's disease	0.00103	0.00366	CcSEcCtD
Ranitidine—Hypotension—Azathioprine—Crohn's disease	0.00103	0.00365	CcSEcCtD
Ranitidine—Cardiac arrest—Prednisone—Crohn's disease	0.00103	0.00364	CcSEcCtD
Ranitidine—Confusional state—Mesalazine—Crohn's disease	0.00101	0.00358	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.001	0.00355	CcSEcCtD
Ranitidine—Anaphylactic shock—Mesalazine—Crohn's disease	0.001	0.00355	CcSEcCtD
Ranitidine—Thrombocytopenia—Mesalazine—Crohn's disease	0.000981	0.00348	CcSEcCtD
Ranitidine—Tachycardia—Mesalazine—Crohn's disease	0.000978	0.00347	CcSEcCtD
Ranitidine—Hyperhidrosis—Mesalazine—Crohn's disease	0.000969	0.00344	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Prednisone—Crohn's disease	0.000952	0.00337	CcSEcCtD
Ranitidine—Hypotension—Mesalazine—Crohn's disease	0.000937	0.00332	CcSEcCtD
Ranitidine—Pancreatitis—Prednisone—Crohn's disease	0.000914	0.00324	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.000913	0.00324	CcSEcCtD
Ranitidine—Feeling abnormal—Azathioprine—Crohn's disease	0.000907	0.00322	CcSEcCtD
Ranitidine—Insomnia—Mesalazine—Crohn's disease	0.000907	0.00321	CcSEcCtD
Ranitidine—Dyspnoea—Mesalazine—Crohn's disease	0.000894	0.00317	CcSEcCtD
Ranitidine—Somnolence—Mesalazine—Crohn's disease	0.000891	0.00316	CcSEcCtD
Ranitidine—Neutropenia—Prednisone—Crohn's disease	0.000872	0.00309	CcSEcCtD
Ranitidine—Abdominal pain—Azathioprine—Crohn's disease	0.00087	0.00308	CcSEcCtD
Ranitidine—Body temperature increased—Azathioprine—Crohn's disease	0.00087	0.00308	CcSEcCtD
Ranitidine—Erectile dysfunction—Prednisone—Crohn's disease	0.000859	0.00305	CcSEcCtD
Ranitidine—Pain—Mesalazine—Crohn's disease	0.000857	0.00304	CcSEcCtD
Ranitidine—Constipation—Mesalazine—Crohn's disease	0.000857	0.00304	CcSEcCtD
Ranitidine—Weight decreased—Prednisone—Crohn's disease	0.000844	0.00299	CcSEcCtD
Ranitidine—Feeling abnormal—Mesalazine—Crohn's disease	0.000826	0.00293	CcSEcCtD
Ranitidine—Hypersensitivity—Azathioprine—Crohn's disease	0.000811	0.00287	CcSEcCtD
Ranitidine—Urticaria—Mesalazine—Crohn's disease	0.000796	0.00282	CcSEcCtD
Ranitidine—Abdominal pain—Mesalazine—Crohn's disease	0.000792	0.00281	CcSEcCtD
Ranitidine—Body temperature increased—Mesalazine—Crohn's disease	0.000792	0.00281	CcSEcCtD
Ranitidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000779	0.018	CbGpPWpGaD
Ranitidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000779	0.018	CbGpPWpGaD
Ranitidine—Bradycardia—Prednisone—Crohn's disease	0.00076	0.00269	CcSEcCtD
Ranitidine—Diarrhoea—Azathioprine—Crohn's disease	0.000753	0.00267	CcSEcCtD
Ranitidine—Hallucination—Prednisone—Crohn's disease	0.000743	0.00263	CcSEcCtD
Ranitidine—Hypersensitivity—Mesalazine—Crohn's disease	0.000739	0.00262	CcSEcCtD
Ranitidine—Dizziness—Azathioprine—Crohn's disease	0.000728	0.00258	CcSEcCtD
Ranitidine—Pruritus—Mesalazine—Crohn's disease	0.000709	0.00251	CcSEcCtD
Ranitidine—Vomiting—Azathioprine—Crohn's disease	0.0007	0.00248	CcSEcCtD
Ranitidine—Rash—Azathioprine—Crohn's disease	0.000694	0.00246	CcSEcCtD
Ranitidine—Dermatitis—Azathioprine—Crohn's disease	0.000693	0.00246	CcSEcCtD
Ranitidine—Headache—Azathioprine—Crohn's disease	0.000689	0.00244	CcSEcCtD
Ranitidine—Diarrhoea—Mesalazine—Crohn's disease	0.000686	0.00243	CcSEcCtD
Ranitidine—Arrhythmia—Prednisone—Crohn's disease	0.000667	0.00236	CcSEcCtD
Ranitidine—Dizziness—Mesalazine—Crohn's disease	0.000663	0.00235	CcSEcCtD
Ranitidine—Alopecia—Prednisone—Crohn's disease	0.00066	0.00234	CcSEcCtD
Ranitidine—Nausea—Azathioprine—Crohn's disease	0.000654	0.00232	CcSEcCtD
Ranitidine—Erythema—Prednisone—Crohn's disease	0.00065	0.0023	CcSEcCtD
Ranitidine—Vomiting—Mesalazine—Crohn's disease	0.000637	0.00226	CcSEcCtD
Ranitidine—Rash—Mesalazine—Crohn's disease	0.000632	0.00224	CcSEcCtD
Ranitidine—Dermatitis—Mesalazine—Crohn's disease	0.000631	0.00224	CcSEcCtD
Ranitidine—Headache—Mesalazine—Crohn's disease	0.000628	0.00223	CcSEcCtD
Ranitidine—Vision blurred—Prednisone—Crohn's disease	0.000612	0.00217	CcSEcCtD
Ranitidine—Ill-defined disorder—Prednisone—Crohn's disease	0.000603	0.00214	CcSEcCtD
Ranitidine—Anaemia—Prednisone—Crohn's disease	0.000601	0.00213	CcSEcCtD
Ranitidine—Agitation—Prednisone—Crohn's disease	0.000597	0.00212	CcSEcCtD
Ranitidine—Nausea—Mesalazine—Crohn's disease	0.000595	0.00211	CcSEcCtD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.000595	0.0138	CbGpPWpGaD
Ranitidine—Angioedema—Prednisone—Crohn's disease	0.000594	0.00211	CcSEcCtD
Ranitidine—Malaise—Prednisone—Crohn's disease	0.000586	0.00208	CcSEcCtD
Ranitidine—Vertigo—Prednisone—Crohn's disease	0.000584	0.00207	CcSEcCtD
Ranitidine—Myalgia—Prednisone—Crohn's disease	0.000553	0.00196	CcSEcCtD
Ranitidine—Arthralgia—Prednisone—Crohn's disease	0.000553	0.00196	CcSEcCtD
Ranitidine—Discomfort—Prednisone—Crohn's disease	0.000547	0.00194	CcSEcCtD
Ranitidine—Anaphylactic shock—Prednisone—Crohn's disease	0.00053	0.00188	CcSEcCtD
Ranitidine—Tachycardia—Prednisone—Crohn's disease	0.000518	0.00184	CcSEcCtD
Ranitidine—Hyperhidrosis—Prednisone—Crohn's disease	0.000513	0.00182	CcSEcCtD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00051	0.0118	CbGpPWpGaD
Ranitidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A5—Crohn's disease	0.000505	0.0117	CbGpPWpGaD
Ranitidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC22A4—Crohn's disease	0.000505	0.0117	CbGpPWpGaD
Ranitidine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000485	0.0112	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.000483	0.0112	CbGpPWpGaD
Ranitidine—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000483	0.00171	CcSEcCtD
Ranitidine—Insomnia—Prednisone—Crohn's disease	0.00048	0.0017	CcSEcCtD
Ranitidine—Constipation—Prednisone—Crohn's disease	0.000454	0.00161	CcSEcCtD
Ranitidine—Feeling abnormal—Prednisone—Crohn's disease	0.000437	0.00155	CcSEcCtD
Ranitidine—Urticaria—Prednisone—Crohn's disease	0.000421	0.00149	CcSEcCtD
Ranitidine—Abdominal pain—Prednisone—Crohn's disease	0.000419	0.00149	CcSEcCtD
Ranitidine—Body temperature increased—Prednisone—Crohn's disease	0.000419	0.00149	CcSEcCtD
Ranitidine—HRH2—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00041	0.0095	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.000391	0.00906	CbGpPWpGaD
Ranitidine—Hypersensitivity—Prednisone—Crohn's disease	0.000391	0.00139	CcSEcCtD
Ranitidine—HRH2—GPCR ligand binding—ACKR2—Crohn's disease	0.000388	0.009	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000376	0.00871	CbGpPWpGaD
Ranitidine—Pruritus—Prednisone—Crohn's disease	0.000375	0.00133	CcSEcCtD
Ranitidine—HRH2—GPCR ligand binding—MLN—Crohn's disease	0.000368	0.00853	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.000364	0.00842	CbGpPWpGaD
Ranitidine—Diarrhoea—Prednisone—Crohn's disease	0.000363	0.00129	CcSEcCtD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.000354	0.0082	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.000354	0.0082	CbGpPWpGaD
Ranitidine—Dizziness—Prednisone—Crohn's disease	0.000351	0.00124	CcSEcCtD
Ranitidine—ABCB1—Allograft Rejection—LRRK2—Crohn's disease	0.00034	0.00788	CbGpPWpGaD
Ranitidine—Vomiting—Prednisone—Crohn's disease	0.000337	0.0012	CcSEcCtD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.000335	0.00776	CbGpPWpGaD
Ranitidine—Rash—Prednisone—Crohn's disease	0.000334	0.00119	CcSEcCtD
Ranitidine—Dermatitis—Prednisone—Crohn's disease	0.000334	0.00118	CcSEcCtD
Ranitidine—Headache—Prednisone—Crohn's disease	0.000332	0.00118	CcSEcCtD
Ranitidine—Nausea—Prednisone—Crohn's disease	0.000315	0.00112	CcSEcCtD
Ranitidine—SLC22A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC11A1—Crohn's disease	0.000315	0.00729	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.000312	0.00722	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—GPX4—Crohn's disease	0.000293	0.00679	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.000259	0.006	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CCR9—Crohn's disease	0.000255	0.00591	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000249	0.00578	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—GPR65—Crohn's disease	0.000237	0.0055	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—SLC22A5—Crohn's disease	0.00023	0.00532	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—SLC22A4—Crohn's disease	0.00023	0.00532	CbGpPWpGaD
Ranitidine—HRH2—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.000228	0.00528	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.000222	0.00514	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.00022	0.00511	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—MLN—Crohn's disease	0.000208	0.00482	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—Crohn's disease	0.000204	0.00473	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—ACKR2—Crohn's disease	0.000199	0.00462	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000195	0.00453	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—MLN—Crohn's disease	0.000189	0.00438	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—Crohn's disease	0.000188	0.00436	CbGpPWpGaD
Ranitidine—CYP1A2—Estrogen Receptor Pathway—STAT3—Crohn's disease	0.000181	0.00418	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.00018	0.00417	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.00018	0.00417	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL17A—Crohn's disease	0.000179	0.00414	CbGpPWpGaD
Ranitidine—CYP3A5—Metapathway biotransformation—GPX4—Crohn's disease	0.000179	0.00414	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CCR6—Crohn's disease	0.000169	0.00392	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL12B—Crohn's disease	0.000166	0.00385	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—GCKR—Crohn's disease	0.000162	0.00375	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—PTGER4—Crohn's disease	0.000149	0.00345	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CCR9—Crohn's disease	0.000144	0.00334	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—SLC11A1—Crohn's disease	0.000143	0.00331	CbGpPWpGaD
Ranitidine—CYP2C19—Metapathway biotransformation—GPX4—Crohn's disease	0.000138	0.0032	CbGpPWpGaD
Ranitidine—ABCB1—HIF-1-alpha transcription factor network—SMAD3—Crohn's disease	0.000135	0.00313	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—GPR65—Crohn's disease	0.000134	0.00311	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCR9—Crohn's disease	0.000131	0.00303	CbGpPWpGaD
Ranitidine—CYP2D6—Metapathway biotransformation—GPX4—Crohn's disease	0.000127	0.00294	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—GCKR—Crohn's disease	0.000127	0.00294	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—GPR65—Crohn's disease	0.000122	0.00282	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL10—Crohn's disease	0.000121	0.00281	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—ACKR2—Crohn's disease	0.000118	0.00273	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	0.000117	0.0027	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	0.000117	0.0027	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	0.000112	0.0026	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—MLN—Crohn's disease	0.000112	0.00259	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL2RA—Crohn's disease	0.000108	0.00251	CbGpPWpGaD
Ranitidine—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000108	0.00249	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TAGAP—Crohn's disease	0.000102	0.00236	CbGpPWpGaD
Ranitidine—CYP2C19—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000101	0.00234	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CCR6—Crohn's disease	9.55e-05	0.00221	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RSPO3—Crohn's disease	8.92e-05	0.00207	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	8.79e-05	0.00204	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CCR6—Crohn's disease	8.67e-05	0.00201	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	8.66e-05	0.00201	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SEL1L—Crohn's disease	8.46e-05	0.00196	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	8.42e-05	0.00195	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—PTGER4—Crohn's disease	8.41e-05	0.00195	CbGpPWpGaD
Ranitidine—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	8.3e-05	0.00192	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—GCKR—Crohn's disease	8.22e-05	0.0019	CbGpPWpGaD
Ranitidine—SLC22A8—SLC-mediated transmembrane transport—ALB—Crohn's disease	7.94e-05	0.00184	CbGpPWpGaD
Ranitidine—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	7.88e-05	0.00183	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	7.84e-05	0.00182	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCR9—Crohn's disease	7.74e-05	0.00179	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—PTGER4—Crohn's disease	7.64e-05	0.00177	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—Crohn's disease	7.62e-05	0.00177	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	7.37e-05	0.00171	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	7.27e-05	0.00168	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—GPR65—Crohn's disease	7.19e-05	0.00167	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL3—Crohn's disease	7.16e-05	0.00166	CbGpPWpGaD
Ranitidine—HRH2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	7.15e-05	0.00166	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IFNG—Crohn's disease	7.14e-05	0.00165	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—RASGRP1—Crohn's disease	6.93e-05	0.00161	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC22A5—Crohn's disease	6.84e-05	0.00158	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC22A4—Crohn's disease	6.84e-05	0.00158	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	6.75e-05	0.00156	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—CXCL8—Crohn's disease	6.64e-05	0.00154	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL3—Crohn's disease	6.5e-05	0.00151	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PLA2G4F—Crohn's disease	6.43e-05	0.00149	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—IL1B—Crohn's disease	6.37e-05	0.00148	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—RASGRP1—Crohn's disease	6.29e-05	0.00146	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	5.74e-05	0.00133	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	5.74e-05	0.00133	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	5.69e-05	0.00132	CbGpPWpGaD
Ranitidine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	5.69e-05	0.00132	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—MTMR3—Crohn's disease	5.46e-05	0.00127	CbGpPWpGaD
Ranitidine—HRH2—GPCR ligand binding—CXCL8—Crohn's disease	5.45e-05	0.00126	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	5.37e-05	0.00125	CbGpPWpGaD
Ranitidine—SLC22A1—SLC-mediated transmembrane transport—ALB—Crohn's disease	5.15e-05	0.00119	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CCR6—Crohn's disease	5.12e-05	0.00119	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—IL2RA—Crohn's disease	5.02e-05	0.00116	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	4.99e-05	0.00116	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—GCKR—Crohn's disease	4.82e-05	0.00112	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RBX1—Crohn's disease	4.63e-05	0.00107	CbGpPWpGaD
Ranitidine—ABCB1—Allograft Rejection—TNF—Crohn's disease	4.62e-05	0.00107	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL2RA—Crohn's disease	4.56e-05	0.00106	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—PTGER4—Crohn's disease	4.51e-05	0.00105	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	4.47e-05	0.00104	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—SLC11A1—Crohn's disease	4.26e-05	0.000987	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—FADS1—Crohn's disease	4.26e-05	0.000986	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—MTMR3—Crohn's disease	4.24e-05	0.000983	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	4.19e-05	0.00097	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—UBE2D1—Crohn's disease	4.06e-05	0.000941	CbGpPWpGaD
Ranitidine—SLC22A8—Transmembrane transport of small molecules—ALB—Crohn's disease	4.03e-05	0.000935	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GPX4—Crohn's disease	3.99e-05	0.000924	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RIPK2—Crohn's disease	3.94e-05	0.000913	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PLA2G4F—Crohn's disease	3.86e-05	0.000894	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—GCKR—Crohn's disease	3.85e-05	0.000892	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL3—Crohn's disease	3.84e-05	0.00089	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PLA2G4F—Crohn's disease	3.77e-05	0.000873	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—RASGRP1—Crohn's disease	3.72e-05	0.000861	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	3.55e-05	0.000822	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Crohn's disease	3.38e-05	0.000783	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—JAK2—Crohn's disease	3.37e-05	0.000781	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SOCS1—Crohn's disease	3.37e-05	0.00078	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—FADS1—Crohn's disease	3.31e-05	0.000766	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—MTMR3—Crohn's disease	3.28e-05	0.00076	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—TYK2—Crohn's disease	3.21e-05	0.000744	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—MTMR3—Crohn's disease	3.2e-05	0.000742	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GPX4—Crohn's disease	3.1e-05	0.000717	CbGpPWpGaD
Ranitidine—HRH2—GPCR downstream signaling—CXCL8—Crohn's disease	3.08e-05	0.000713	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—JAK2—Crohn's disease	3.06e-05	0.00071	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—MTMR3—Crohn's disease	3.02e-05	0.000699	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	3.01e-05	0.000697	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—GCKR—Crohn's disease	2.99e-05	0.000693	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—SMAD3—Crohn's disease	2.91e-05	0.000674	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—CXCL8—Crohn's disease	2.8e-05	0.000648	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL2RA—Crohn's disease	2.69e-05	0.000624	CbGpPWpGaD
Ranitidine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	2.62e-05	0.000606	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—MTMR3—Crohn's disease	2.56e-05	0.000592	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—FADS1—Crohn's disease	2.56e-05	0.000592	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—FADS1—Crohn's disease	2.49e-05	0.000578	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GPX4—Crohn's disease	2.39e-05	0.000555	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—FADS1—Crohn's disease	2.35e-05	0.000545	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GPX4—Crohn's disease	2.34e-05	0.000541	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	2.32e-05	0.000538	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—GCKR—Crohn's disease	2.31e-05	0.000536	CbGpPWpGaD
Ranitidine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—Crohn's disease	2.28e-05	0.000528	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—GCKR—Crohn's disease	2.26e-05	0.000523	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GPX4—Crohn's disease	2.2e-05	0.00051	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—GCKR—Crohn's disease	2.13e-05	0.000493	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—FADS1—Crohn's disease	1.99e-05	0.000461	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—MTMR3—Crohn's disease	1.97e-05	0.000457	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—TYK2—Crohn's disease	1.9e-05	0.000439	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GPX4—Crohn's disease	1.87e-05	0.000432	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—JAK2—Crohn's disease	1.81e-05	0.000419	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—GCKR—Crohn's disease	1.8e-05	0.000417	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.65e-05	0.000383	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—CXCL8—Crohn's disease	1.65e-05	0.000383	CbGpPWpGaD
Ranitidine—HRH2—Signaling by GPCR—IL6—Crohn's disease	1.57e-05	0.000364	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—FADS1—Crohn's disease	1.54e-05	0.000356	CbGpPWpGaD
Ranitidine—ABCB1—Transmembrane transport of small molecules—ALB—Crohn's disease	1.53e-05	0.000355	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.45e-05	0.000335	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GPX4—Crohn's disease	1.44e-05	0.000333	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—GCKR—Crohn's disease	1.39e-05	0.000322	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—STAT3—Crohn's disease	1.33e-05	0.000308	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	1.29e-05	0.000298	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—ALB—Crohn's disease	1.23e-05	0.000284	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	1.13e-05	0.000261	CbGpPWpGaD
Ranitidine—SLC22A1—Metabolism—PTGS2—Crohn's disease	1.07e-05	0.000248	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—ALB—Crohn's disease	9.52e-06	0.00022	CbGpPWpGaD
Ranitidine—HRH2—Signaling Pathways—IL6—Crohn's disease	9.28e-06	0.000215	CbGpPWpGaD
Ranitidine—CYP3A5—Metabolism—PTGS2—Crohn's disease	8.33e-06	0.000193	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—ALB—Crohn's disease	7.36e-06	0.00017	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—ALB—Crohn's disease	7.18e-06	0.000166	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—ALB—Crohn's disease	6.77e-06	0.000157	CbGpPWpGaD
Ranitidine—CYP2C19—Metabolism—PTGS2—Crohn's disease	6.44e-06	0.000149	CbGpPWpGaD
Ranitidine—ABCB1—Metabolism—PTGS2—Crohn's disease	6.28e-06	0.000146	CbGpPWpGaD
Ranitidine—CYP2D6—Metabolism—PTGS2—Crohn's disease	5.92e-06	0.000137	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—ALB—Crohn's disease	5.73e-06	0.000133	CbGpPWpGaD
Ranitidine—CYP1A2—Metabolism—PTGS2—Crohn's disease	5.02e-06	0.000116	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—ALB—Crohn's disease	4.42e-06	0.000103	CbGpPWpGaD
Ranitidine—CYP3A4—Metabolism—PTGS2—Crohn's disease	3.87e-06	8.97e-05	CbGpPWpGaD
